Thalidomide Exerts Distinct Molecular Antileukemic Effects

GSE15913

Homo sapiens

39 Downloadable Samples

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

Thalidomide Exerts Distinct Molecular Antileukemic Effects and Combined Thalidomide/Fludarabine Therapy is Clinically Effective in High-Risk Chronic Lymphocytic Leukemia

PubMed ID

19440214

Publication Title

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.

Total Samples

Submitter’s Institution

Charit

Authors

Giannopoulos K, Dmoszynska A, Kowal M, Wasik-Szczepanek E, Bojarska-Junak A, Rolinski J, Döhner H, Stilgenbauer S, Bullinger L

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-15913

No rows found